Endotronix Inc. (Edwards Lifesciences Corp.)

Company Overview

Endotronix Inc. is a privately held medical technology company whose focus is on the creation of innovative implantable devices used in the management of chronic conditions, especially heart failure. The company’s first product, the Cordella Heart Failure System, features implantable sensor technology and the ability to remotely monitor heart failure patients remotely, providing real-time information to healthcare providers for better patient management, thus improving outcomes for patients diagnosed with heart failure. This system aims to improve the accuracy of heart failure management by continuously monitoring key cardiovascular parameters such as pulmonary artery pressure.

The company was established with the idea of solving the increasing global burden of heart failure, one of the leading causes of hospitalization and mortality. Endotronix specializes in developing digital health solutions and IRPM devices that enable healthcare providers to remotely monitor and manage patients’ conditions. Endotronix is strong in North America, but it is expanding into the global market, innovating with cutting-edge technology in the field of medical devices to improve the quality of care and patient outcomes in chronic disease management.

Company's Business Segments

• Cardiovascular Care Management : The company offers medical devices and a digital health management platform for patients with chronic heart failure (HF).